Publications by authors named "Emmanuel A A Teviu"
Article Synopsis
- The RTS,S malaria vaccine has been authorized for use in areas with moderate to high malaria transmission, specifically targeting children aged 12-59 months in Ghana.
- A study conducted from 2020 to 2022 found that the vaccine reduced uncomplicated malaria cases by 33%, though the rate of malaria incidence averted showed a decline over time.
- Researchers concluded that the vaccine effectively lowers malaria burden, but decreasing protective immunity as children age highlights the need for better vaccination uptake and malaria control strategies.
Background: Disproportionately high rates of COVID-19 infection among health workers prompts the need to identify the risk factors to help guide the design and implementation of interventions. The aim of this study was to characterize the risk factors for COVID-19 infection among health workers.
Methods: A case-control study was designed to recruit 154 health workers who tested positive for the COVID-19 virus and 308 who tested negative from 8 hospitals and 11 health directorates in the Bono East Region of Ghana.